Rs similarity and differences among Burkitt lymphoma subtypes. Blood 2011, 117:3596608. 11. Lenze D, Leoncini L, Hummel M, Volinia S, Liu CG, Amato T, De Falco G, Githanga J, Horn H, Nyagol J, Ott G, Palatini J, Pfreundschuh M, Rogena E, Rosenwald A, Siebert R, Croce CM, Stein H: The distinct epidemiologic12.13.14.15.16.17.18.19.20. 21.22.23. 24.25.26.27.28.29.30.31.subtypes of Burkitt lymphoma share a homogenous micro RNA profile distinct from diffuse significant B-cell lymphoma. Leukemia 2011, 25:1869876. Onnis A, Navari M, Antonicelli G, Morettini F, Mannucci S, De Falco G, Vigorito E, Leoncini L: Epstein-Barr nuclear antigen 1 induces expression on the cellular microRNA hsa-miR-127 and impairing B-cell differentiation in EBV-infected memory B cells. New insights into the pathogenesis of Burkitt lymphoma. Blood Cancer J 2012, 2:e84. Cai X, Sch er A, Lu S, Bilello JP, Desrosiers RC, Edwards R, Raab-Traub N, Cullen BR: Epstein-Barr virus microRNAs are evolutionarily conserved and differentially expressed. PLoS Pathog 2006, 3:e23. Qiu J, Cosmopoulos K, Pegtel M, Hopmans E, Murray P, Middeldorp J, Shapiro M, Thorley-Lawson DA: A novel persistence associated EBV miRNA expression profile is disrupted in neoplasia. PLoS Pathog 2011, 7:e1002193. Nourse JP, Crooks P, Keane C, Nguyen-Van D, Mujaj S, Ross N, Jones K, Vari F, Han E, Trappe R, Fink S, Gandhi MK: Expression profiling of Epstein-Barr virus-encoded microRNAs from paraffin-embedded formalin-fixed major Epstein-Barr virus-positive B-cell lymphoma samples.PEPA supplier J Virol Strategies 2012, 184:464. Ramakrishnan R, Donahue H, Garcia D, Tan J, Shimizu N, Rice AP, Ling PD: Epstein-Barr virus BART9 miRNA modulates LMP1 levels and impacts development price of nasal NK T cell lymphomas. PLoS 1 2011, six:e27271. Leucci E, Onnis A, Cocco M, De Falco G, Imperatore F, Giuseppina A, Costanzo V, Cerino G, Mannucci S, Cantisani R, Nyagol J, Mwanda W, Iriso R, Owang M, Schurfeld K, Bellan C, Lazzi S, Leoncini L: B-cell differentiation in EBV-positive Burkitt lymphoma is impaired at posttranscriptional level by miRNA-altered expression. Int J Cancer 2010, 126:1316326. De Falco G, Antonicelli G, Onnis A, Lazzi S, Bellan C, Leoncini L: Part of EBV in microRNA dysregulation in burkitt lymphoma. Semin Cancer Biol 2009, 19:40116. Onnis A, De Falco G, Antonicelli G, Onorati M, Bellan C, Sherman O, Sayed S, Leoncini L: Alteration of microRNAs regulated by c-Myc in burkitt lymphoma.6-Amino-1-hexanol medchemexpress PLoS One 2010, 5:1.PMID:24103058 De Falco G, Rogena EA, Leoncini L: Infectious agents and lymphoma. Semin Diagn Pathol 2011, 28:17887. Ryan JL, Fan H, Glaser SL, Schichman SA, Raab-Traub N, Gulley ML: Epstein-Barr virus quantitation by real-time PCR targeting several gene segments: a novel strategy to screen for the virus in paraffin-embedded tissue and plasma. J Mol Diagn 2004, 6:3785. Ach RA, Wang H, Curry B: Measuring microRNAs: comparisons of microarray and quantitative PCR measurements, and of distinct total RNA prep methods. BMC Biotechnol 2008, eight:69. Storey JD, Siegmund D: Approximate p-values for local sequence alignments: numerical studies. J Comput Biol 2001, 8:54956. Sethupathy P, Corda B, Hatzigeorgiou AG: TarBase: a complete database of experimentally supported animal microRNA targets. RNA 2006, 12:19297. Ambros V, Bartel B, Bartel DP, Burge CB, Carrington JC, Chen X, Dreyfuss G, Eddy SR, Griffiths-Jones S, Marshall M, Matzke M, Ruvkun G, Tuschl T: A uniform method for microRNA annotation. RNA 2003, 9:27779. Jenssen TK, Laegreid A, Komorowski.